thanks zuckerman for your big mistake.
Should have done your dd short. When this announced and significantly higher eps were going to $250's
By Zacks Equity Research
Zacks Rank #1: Tesla’s Zacks Rank #1 (Strong Buy)
shorts will be in big timr trouble.
FDA Gave GALE SPA( Special Protocol Assessment) for Phase III Neuvax, So shorts right and FDA wrong, don't think so. LONG
this says it all.
Motley Fool 2/16/14